Page results
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Wes Streeting, health and social care secretary, and Jess Phillips, minister for safeguarding, joined Sadiq Khan, mayor of London, and Kaya Comer-Schwartz, deputy mayor for policing and crime, at UCLH’s Lighthouse to announce a national roll-out of Child Houses to all NHS regions.
-
Information for patients (or anyone who is involved in their care) who have undergone implantation of an Intrathecal Baclofen Pump under the care of the team at this hospital.
-
Professor Manjit Matharu's major research interests include migraine, trigeminal autonomic cephalalgias, facial pain, neurostimulation for intractable headaches, spontaneous intracranial hypotension and other headache disorders in hypermobility syndromes.
-
This page explains what to do if you think your IBD symptoms have returned and who to contact for support.
-
Preterm infants do not get used to repeated pain in the way that full-term infants, children and adults do habituate to pain, finds a study at UCLH and UCL.
-
This page is for parents, carers and family members who are acting as comforters and carers for children and young people having radioactive iodine (131I) treatment.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for cancer patients receiving immunotherapy treatment.
File results
-
FOI/2023/0099 - Number of autoclaves used at Trust
-
FOI/2021/0284 - Sleep respiratory service
-
FOI/2023/0086 - Number/ wait times for MRI scans for multiple sclerosis/ dementia/ prostate/ pancreatic cancer
-
FOI/2023/0083 - Software systems/ suppliers used at Trust
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0075 - Attrition rates for staff working in advanced practice roles
-
FOI/2023/0073 - Telephony and UC/ collaboration, Microsoft 365 licence and on-premise or cloud storage
-
FOI/2023/0041 - International recruitment